Cascade Prodrug Awarded Federal Economic Stimulus Grant

EUGENE, Ore. – (October 29, 2010) – Cascade Prodrug, Inc. was awarded a Qualifying Therapeutic Discovery Grant in the amount of $244,479. “The grant will facilitate the preclinical development of our lead compound CPD100, a hypoxia-activated prodrug for the treatment of cancer,” said August Sick, Cascade’s Cofounder and Managing Director. Cascade Prodrug’s platform technology provides chemical conversion of approved chemotherapy drugs into potentially safer and more effective prodrugs for treating cancer.

About CascadeProdrug

No Comments

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Powered by WishList Member - Membership Software